De Fiesta, Marilou L.

HRN: 28-85-42  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2026
CEFTRIAXONE 1G (VIAL)
04/28/2026
05/04/2026
IV
1g
Q12
Hernia Nucleus Pulposus
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: